<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38878148</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-8312</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The international journal of cardiovascular imaging</Title><ISOAbbreviation>Int J Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>CMR-based cardiac phenotyping in different forms of heart failure.</ArticleTitle><Pagination><StartPage>1585</StartPage><EndPage>1596</EndPage><MedlinePgn>1585-1596</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10554-024-03145-4</ELocationID><Abstract><AbstractText>Heart failure (HF) is a heterogenous disease requiring precise diagnostics and knowledge of pathophysiological processes. Since structural and functional imaging data are scarce we hypothesized that cardiac magnetic resonance (CMR)-based analyses would provide accurate characterization and mechanistic insights into different HF groups comprising preserved (HFpEF), mid-range (HFmrEF) and reduced ejection fraction (HFrEF). 22 HFpEF, 17 HFmrEF and 15 HFrEF patients as well as 19 healthy volunteers were included. CMR image assessment contained left atrial (LA) and left ventricular (LV) volumetric evaluation as well as left atrioventricular coupling index (LACI). Furthermore, CMR feature-tracking included LV and LA strain in terms of reservoir (Es), conduit (Ee) and active boosterpump (Ea) function. CMR-based tissue characterization comprised T1 mapping as well as late-gadolinium enhancement (LGE) analyses. HFpEF patients showed predominant atrial impairment (Es 20.8%vs.25.4%, p&#x2009;=&#x2009;0.02 and Ee 8.3%vs.13.5%, p&#x2009;=&#x2009;0.001) and increased LACI compared to healthy controls (14.5%vs.23.3%, p&#x2009;=&#x2009;0.004). Patients with HFmrEF showed LV enlargement but mostly preserved LA function with a compensatory increase in LA boosterpump (LA Ea: 15.0%, p&#x2009;=&#x2009;0.049). In HFrEF LA and LV functional impairment was documented (Es: 14.2%, Ee: 5.4% p&#x2009;&lt;&#x2009;0.001 respectively; Ea: 8.8%, p&#x2009;=&#x2009;0.02). This was paralleled by non-invasively assessed progressive fibrosis (T1 mapping and LGE; HFrEF&#x2009;&gt;&#x2009;HFmrEF&#x2009;&gt;&#x2009;HFpEF). CMR-imaging reveals insights into HF phenotypes with mainly atrial affection in HFpEF, ventricular affection with atrial compensation in HFmrEF and global impairment in HFrEF paralleled by progressive LV fibrosis. These data suggest a necessity for a personalized HF management based on imaging findings for future optimized patient management.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Torben</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Pneumology, University Medical Center G&#xf6;ttingen, Georg-August University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre of Cardiovascular Research (DZHK), partner site Lower Saxony, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Backhaus</LastName><ForeName>S&#xf6;ren J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Campus Kerckhoff of the Justus-Liebig-Universit&#xe4;t Gie&#xdf;en, Kerckhoff-Clinic, Bad Nauheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulz</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Pneumology, University Medical Center G&#xf6;ttingen, Georg-August University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre of Cardiovascular Research (DZHK), partner site Lower Saxony, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashemi</LastName><ForeName>Djawid</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Charit&#xe9; Campus Virchow Clinic, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evertz</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Pneumology, University Medical Center G&#xf6;ttingen, Georg-August University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre of Cardiovascular Research (DZHK), partner site Lower Saxony, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowallick</LastName><ForeName>Johannes T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>German Centre of Cardiovascular Research (DZHK), partner site Lower Saxony, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Diagnostic and Interventional Radiology, University Medical Center G&#xf6;ttingen, Georg-August University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasenfu&#xdf;</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Pneumology, University Medical Center G&#xf6;ttingen, Georg-August University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre of Cardiovascular Research (DZHK), partner site Lower Saxony, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelle</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology, Charit&#xe9; Campus Virchow Clinic, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuster</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Pneumology, University Medical Center G&#xf6;ttingen, Georg-August University, G&#xf6;ttingen, Germany. andreas_schuster@gmx.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre of Cardiovascular Research (DZHK), partner site Lower Saxony, G&#xf6;ttingen, Germany. andreas_schuster@gmx.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Cardiovasc Imaging</MedlineTA><NlmUniqueID>100969716</NlmUniqueID><ISSNLinking>1569-5794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="Y">Ventricular Function, Left</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="Y">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="Y">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016279" MajorTopicYN="Y">Atrial Function, Left</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019028" MajorTopicYN="Y">Magnetic Resonance Imaging, Cine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020257" MajorTopicYN="N">Ventricular Remodeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064752" MajorTopicYN="N">Atrial Remodeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CMR feature-tracking</Keyword><Keyword MajorTopicYN="N">CMR imaging</Keyword><Keyword MajorTopicYN="N">CMR-based tissue characterization</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Left atrioventricular coupling index</Keyword><Keyword MajorTopicYN="N">Myocardial strain assessment</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>15</Day><Hour>14</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>15</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38878148</ArticleId><ArticleId IdType="pmc">PMC11258094</ArticleId><ArticleId IdType="doi">10.1007/s10554-024-03145-4</ArticleId><ArticleId IdType="pii">10.1007/s10554-024-03145-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry. Eur J Heart Fail. 2017;19:1574&#x2013;1585. doi: 10.1002/ejhf.813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.813</ArticleId><ArticleId IdType="pubmed">28386917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129&#x2013;2200. doi: 10.1093/eurheartj/ehw128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw128</ArticleId><ArticleId IdType="pubmed">27206819</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599&#x2013;3726. doi: 10.1093/eurheartj/ehab368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab368</ArticleId><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JJ, Park JB, Park JH, Cho GY. Global longitudinal strain to predict mortality in patients with acute heart failure. J Am Coll Cardiol. 2018;71:1947&#x2013;1957. doi: 10.1016/j.jacc.2018.02.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.02.064</ArticleId><ArticleId IdType="pubmed">29724346</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitel I, Stiermaier T, Lange T, et al. Cardiac magnetic resonance myocardial feature tracking for optimized prediction of cardiovascular events following myocardial infarction. JACC Cardiovasc Imaging. 2018;11:1433&#x2013;1444. doi: 10.1016/j.jcmg.2017.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2017.11.034</ArticleId><ArticleId IdType="pubmed">29454776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kammerlander AA, Kraiger JA, Nitsche C, et al. Global longitudinal strain by CMR feature tracking is associated with outcome in HFPEF. JACC Cardiovasc Imaging. 2019;12:1585&#x2013;1587. doi: 10.1016/j.jcmg.2019.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2019.02.016</ArticleId><ArticleId IdType="pubmed">31005535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange T, Gertz RJ, Schulz A, et al. Impact of myocardial deformation on risk prediction in patients following acute myocardial infarction. Front Cardiovascular Med. 2023;10:1199936. doi: 10.3389/fcvm.2023.1199936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1199936</ArticleId><ArticleId IdType="pmc">PMC10449121</ArticleId><ArticleId IdType="pubmed">37636296</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster A, Backhaus SJ, Stiermaier T, et al. Left atrial function with MRI enables prediction of cardiovascular events after myocardial infarction: insights from the AIDA STEMI and TATORT NSTEMI trials. Radiology. 2019;293:292&#x2013;302. doi: 10.1148/radiol.2019190559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2019190559</ArticleId><ArticleId IdType="pubmed">31526253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Yum B, Palumbo MC, et al. Left atrial strain impairment precedes geometric remodeling as a marker of post-myocardial infarction diastolic dysfunction. JACC Cardiovasc Imaging. 2020;13:2099&#x2013;2113. doi: 10.1016/j.jcmg.2020.05.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.041</ArticleId><ArticleId IdType="pmc">PMC7554167</ArticleId><ArticleId IdType="pubmed">32828776</ArticleId></ArticleIdList></Reference><Reference><Citation>Backhaus SJ, Stiermaier T, Lange T, et al. Atrial mechanics and their prognostic impact in Takotsubo syndrome: a cardiovascular magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. 2019;20:1059&#x2013;1069. doi: 10.1093/ehjci/jey219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jey219</ArticleId><ArticleId IdType="pubmed">30649241</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezel T, AmbaleVenkatesh B, Kato Y, et al. Left atrioventricular coupling index to predict incident heart failure: the multi-ethnic study of atherosclerosis. Front Cardiovasc Med. 2021;8:704611. doi: 10.3389/fcvm.2021.704611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.704611</ArticleId><ArticleId IdType="pmc">PMC8442844</ArticleId><ArticleId IdType="pubmed">34540915</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Rimpler J, Backhaus SJ, Hartmann FP, et al. Impact of temporal and spatial resolution on atrial feature tracking cardiovascular magnetic resonance imaging. Int J Cardiol. 2023;396:131563. doi: 10.1016/j.ijcard.2023.131563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2023.131563</ArticleId><ArticleId IdType="pubmed">37926379</ArticleId></ArticleIdList></Reference><Reference><Citation>Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016;18:89. doi: 10.1186/s12968-016-0308-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-016-0308-4</ArticleId><ArticleId IdType="pmc">PMC5129251</ArticleId><ArticleId IdType="pubmed">27899132</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustafa A, Khan MS, Alsamman MA, Jamal F, Atalay MK. Prognostic significance of T1 mapping parameters in heart failure with preserved ejection fraction: a systematic review. Heart Fail Rev. 2021;26:1325&#x2013;1331. doi: 10.1007/s10741-020-09958-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-020-09958-4</ArticleId><ArticleId IdType="pubmed">32405810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez B, Ravassa S, Moreno MU, et al. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol. 2021;18:479&#x2013;498. doi: 10.1038/s41569-020-00504-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00504-1</ArticleId><ArticleId IdType="pubmed">33568808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Wang Y, Zhao S, Lu M. Detection of myocardial fibrosis: Where we stand. Front Cardiovasc Med. 2022;9:926378. doi: 10.3389/fcvm.2022.926378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.926378</ArticleId><ArticleId IdType="pmc">PMC9557071</ArticleId><ArticleId IdType="pubmed">36247487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemi D, Motzkus L, Blum M, et al. Myocardial deformation assessed among heart failure entities by cardiovascular magnetic resonance imaging. ESC Heart Fail. 2021;8:890&#x2013;897. doi: 10.1002/ehf2.13193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13193</ArticleId><ArticleId IdType="pmc">PMC8006725</ArticleId><ArticleId IdType="pubmed">33539681</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanacli R, Hashemi D, Lapinskas T, et al. Range variability in CMR feature tracking multilayer strain across different stages of heart failure. Sci Rep. 2019;9:16478. doi: 10.1038/s41598-019-52683-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52683-8</ArticleId><ArticleId IdType="pmc">PMC6848170</ArticleId><ArticleId IdType="pubmed">31712641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemi D, Doeblin P, Blum M, et al. CMR detects decreased myocardial deformation in asymptomatic patients at risk for heart failure. Front Cardiovasc Med. 2022;9:1091768. doi: 10.3389/fcvm.2022.1091768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1091768</ArticleId><ArticleId IdType="pmc">PMC9849678</ArticleId><ArticleId IdType="pubmed">36684590</ArticleId></ArticleIdList></Reference><Reference><Citation>Doeblin P, Hashemi D, Tanacli R, et al. CMR tissue characterization in patients with HFmrEF. J Clin Med. 2019;8:1877. doi: 10.3390/jcm8111877.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8111877</ArticleId><ArticleId IdType="pmc">PMC6912482</ArticleId><ArticleId IdType="pubmed">31694263</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum M, Hashemi D, Motzkus LA, et al. Variability of myocardial strain during isometric exercise in subjects with and without heart failure. Front Cardiovasc Med. 2020;7:111. doi: 10.3389/fcvm.2020.00111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.00111</ArticleId><ArticleId IdType="pmc">PMC7344153</ArticleId><ArticleId IdType="pubmed">32714945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemi D, Doeblin P, Blum M, et al. Reduced functional capacity is associated with the proportion of impaired myocardial deformation assessed in heart failure patients by CMR. Front Cardiovasc Med. 2023;10:1038337. doi: 10.3389/fcvm.2023.1038337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1038337</ArticleId><ArticleId IdType="pmc">PMC9947709</ArticleId><ArticleId IdType="pubmed">36844739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange T, Backhaus SJ, Beuthner BE, et al. Functional and structural reverse myocardial remodeling following transcatheter aortic valve replacement: a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2022;24:45. doi: 10.1186/s12968-022-00874-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-022-00874-0</ArticleId><ArticleId IdType="pmc">PMC9331125</ArticleId><ArticleId IdType="pubmed">35897100</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezel T, Venkatesh BA, De Vasconcellos HD, et al. Left Atrioventricular coupling index as a prognostic marker of cardiovascular events: the MESA study. Hypertension. 2021;78:661&#x2013;671. doi: 10.1161/HYPERTENSIONAHA.121.17339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.121.17339</ArticleId><ArticleId IdType="pmc">PMC8363553</ArticleId><ArticleId IdType="pubmed">34225471</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging. 2016;9:e004077. doi: 10.1161/CIRCIMAGING.115.004077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.115.004077</ArticleId><ArticleId IdType="pubmed">27009468</ArticleId></ArticleIdList></Reference><Reference><Citation>Backhaus SJ, Rosel SF, Stiermaier T, et al. Left-atrial long-axis shortening allows effective quantification of atrial function and optimized risk prediction following acute myocardial infarction. Eur Heart J Open. 2022;2:oeac053. doi: 10.1093/ehjopen/oeac053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjopen/oeac053</ArticleId><ArticleId IdType="pmc">PMC9574426</ArticleId><ArticleId IdType="pubmed">36268539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowallick JT, Kutty S, Edelmann F, et al. Quantification of left atrial strain and strain rate using cardiovascular magnetic resonance myocardial feature tracking: a feasibility study. J Cardiovasc Magn Reson. 2014;16:60. doi: 10.1186/s12968-014-0060-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-014-0060-6</ArticleId><ArticleId IdType="pmc">PMC4422260</ArticleId><ArticleId IdType="pubmed">25196447</ArticleId></ArticleIdList></Reference><Reference><Citation>von Roeder M, Blazek S, Rommel KP, et al. Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure. Clin Res Cardiol. 2022;111:1028&#x2013;1039. doi: 10.1007/s00392-021-01982-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-021-01982-0</ArticleId><ArticleId IdType="pmc">PMC9424148</ArticleId><ArticleId IdType="pubmed">34932171</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas L, Marwick TH, Popescu BA, Donal E, Badano LP. Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:1961&#x2013;1977. doi: 10.1016/j.jacc.2019.01.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.01.059</ArticleId><ArticleId IdType="pubmed">31000000</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Yin G, Jiang Y, Song L, Zhao S, Lu M. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study. J Cardiovasc Magn Reson. 2020;22:1. doi: 10.1186/s12968-019-0589-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-019-0589-5</ArticleId><ArticleId IdType="pmc">PMC6939338</ArticleId><ArticleId IdType="pubmed">31898543</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol. 2012;59:442&#x2013;451. doi: 10.1016/j.jacc.2011.09.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.09.062</ArticleId><ArticleId IdType="pubmed">22281246</ArticleId></ArticleIdList></Reference><Reference><Citation>Backhaus SJ, Lange T, Schulz A, et al. Cardiovascular magnetic resonance rest and exercise-stress left atrioventricular coupling index to detect diastolic dysfunction. Am J Physiol Heart Circ Physiol. 2023;324:H686&#x2013;H695. doi: 10.1152/ajpheart.00081.2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00081.2023</ArticleId><ArticleId IdType="pubmed">36897745</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbrugge FH, Omote K, Reddy YNV, Sorimachi H, Obokata M, Borlaug BA. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality. Eur Heart J. 2022;43:1941&#x2013;1951. doi: 10.1093/eurheartj/ehab911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab911</ArticleId><ArticleId IdType="pmc">PMC9649913</ArticleId><ArticleId IdType="pubmed">35139159</ArticleId></ArticleIdList></Reference><Reference><Citation>von Roeder M, Rommel KP, Kowallick JT, et al. Influence of left atrial function on exercise capacity and left ventricular function in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging. 2017;10(4):e005467. doi: 10.1161/CIRCIMAGING.116.005467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.116.005467</ArticleId><ArticleId IdType="pubmed">28360259</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel RB, Lam CSP, Svedlund S, et al. Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study. Sci Rep. 2021;11:4885. doi: 10.1038/s41598-021-84133-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84133-9</ArticleId><ArticleId IdType="pmc">PMC7921666</ArticleId><ArticleId IdType="pubmed">33649383</ArticleId></ArticleIdList></Reference><Reference><Citation>Primessnig U, Schonleitner P, Holl A, et al. el pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction. Eur J Heart Fail. 2016;18:987&#x2013;997. doi: 10.1002/ejhf.524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.524</ArticleId><ArticleId IdType="pubmed">27135883</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yang S, Hao S, et al. Myocardial fibrosis and prognosis in heart failure with preserved ejection fraction: a pooled analysis of 12 cohort studies. Eur Radiol. 2023;34(3):1854&#x2013;1862. doi: 10.1007/s00330-023-10218-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-023-10218-w</ArticleId><ArticleId IdType="pubmed">37658896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosch S, Kresoja KP, Besler C, et al. Characteristics of heart failure with preserved ejection fraction across the range of left ventricular ejection fraction. Circulation. 2022;146:506&#x2013;518. doi: 10.1161/CIRCULATIONAHA.122.059280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059280</ArticleId><ArticleId IdType="pubmed">35862208</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MA, Yang EY, Zhan Y, et al. Association of left atrial volume index and all-cause mortality in patients referred for routine cardiovascular magnetic resonance: a multicenter study. J Cardiovasc Magn Reson. 2019;21:4. doi: 10.1186/s12968-018-0517-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-018-0517-0</ArticleId><ArticleId IdType="pmc">PMC6322235</ArticleId><ArticleId IdType="pubmed">30612579</ArticleId></ArticleIdList></Reference><Reference><Citation>Backhaus SJ, Lange T, George EF, et al. Exercise-stress real-time cardiac magnetic resonance imaging for non-invasive characterisation of heart failure with preserved ejection fraction: the HFpEF stress trial. Circulation. 2021;143(15):1484&#x2013;1498. doi: 10.1161/CIRCULATIONAHA.120.051542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.051542</ArticleId><ArticleId IdType="pubmed">33472397</ArticleId></ArticleIdList></Reference><Reference><Citation>Backhaus SJ, Rosel SF, Schulz A, et al. RT-CMR imaging for noninvasive characterization of hfpef: medium-term outcomes of the HFpEF stress trial. JACC Cardiovasc Imaging. 2022;15:943&#x2013;945. doi: 10.1016/j.jcmg.2021.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.11.013</ArticleId><ArticleId IdType="pubmed">35512961</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau C, Elshibly MMM, Kanagala P, Khoo JP, Arnold JR, Hothi SS. The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction. Front Cardiovasc Med. 2022;9:922398. doi: 10.3389/fcvm.2022.922398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.922398</ArticleId><ArticleId IdType="pmc">PMC9339656</ArticleId><ArticleId IdType="pubmed">35924215</ArticleId></ArticleIdList></Reference><Reference><Citation>Peigh G, Shah SJ, Patel RB. Left atrial myopathy in atrial fibrillation and heart failure: clinical implications, mechanisms, and therapeutic targets. Curr Heart Fail Rep. 2021;18:85&#x2013;98. doi: 10.1007/s11897-021-00510-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11897-021-00510-5</ArticleId><ArticleId IdType="pmc">PMC8994870</ArticleId><ArticleId IdType="pubmed">33864224</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrzad R, Rajab M, Spodick DH. The three integrated phases of left atrial macrophysiology and their interactions. Int J Mol Sci. 2014;15:15146&#x2013;15160. doi: 10.3390/ijms150915146.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms150915146</ArticleId><ArticleId IdType="pmc">PMC4200839</ArticleId><ArticleId IdType="pubmed">25167138</ArticleId></ArticleIdList></Reference><Reference><Citation>Guichard JB, Nattel S. Atrial cardiomyopathy: a useful notion in cardiac disease management or a passing fad? J Am Coll Cardiol. 2017;70:756&#x2013;765. doi: 10.1016/j.jacc.2017.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.06.033</ArticleId><ArticleId IdType="pubmed">28774383</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffeis C, Morris DA, Belyavskiy E, et al. Left atrial function and maximal exercise capacity in heart failure with preserved and mid-range ejection fraction. ESC Heart Fail. 2021;8:116&#x2013;128. doi: 10.1002/ehf2.13143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13143</ArticleId><ArticleId IdType="pmc">PMC7835603</ArticleId><ArticleId IdType="pubmed">33295106</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu JJ, Ziaeian B, Fonarow GC. Heart failure with mid-range (borderline) ejection fraction: clinical implications and future directions. JACC Heart Fail. 2017;5:763&#x2013;771. doi: 10.1016/j.jchf.2017.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2017.06.013</ArticleId><ArticleId IdType="pmc">PMC6668914</ArticleId><ArticleId IdType="pubmed">29032140</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed BH, Daruwalla V, Cheng JY, et al. Prognostic utility and clinical significance of cardiac mechanics in heart failure with preserved ejection fraction: importance of left atrial strain. Circ Cardiovasc Imaging. 2016 doi: 10.1161/CIRCIMAGING.115.003754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.115.003754</ArticleId><ArticleId IdType="pmc">PMC4780261</ArticleId><ArticleId IdType="pubmed">26941415</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon MG, Hwang IC, Lee HJ, et al. Reverse remodeling assessed by left atrial and ventricular strain reflects treatment response to sacubitril/valsartan. JACC Cardiovasc Imaging. 2022;15:1525&#x2013;1541. doi: 10.1016/j.jcmg.2022.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2022.03.019</ArticleId><ArticleId IdType="pubmed">36075612</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiermaier T, Lange T, Chiribiri A, et al. Left ventricular myocardial deformation in Takotsubo syndrome: a cardiovascular magnetic resonance myocardial feature tracking study. Eur Radiol. 2018;28:5160&#x2013;5170. doi: 10.1007/s00330-018-5475-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-018-5475-2</ArticleId><ArticleId IdType="pubmed">29882071</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezel T, Michos ED, Varadarajan V, et al. Prognostic value of a left atrioventricular coupling index in pre-and post-menopausal women from the multi-ethnic study of atherosclerosis. Front Cardiovasc Med. 2022;9:1066849. doi: 10.3389/fcvm.2022.1066849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1066849</ArticleId><ArticleId IdType="pmc">PMC9719991</ArticleId><ArticleId IdType="pubmed">36479563</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Zheng G, Donner DG, et al. Cardiovascular magnetic resonance imaging for sequential assessment of cardiac fibrosis in mice: technical advancements and reverse translation. Am J Physiol Heart Circ Physiol. 2024;326:H1&#x2013;H24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11213480</ArticleId><ArticleId IdType="pubmed">37921664</ArticleId></ArticleIdList></Reference><Reference><Citation>Celutkiene J, Plymen CM, Flachskampf FA, et al. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. position statement on behalf of the heart failure association of the European society of cardiology. Eur J Heart Fail. 2018;20:1615&#x2013;1633. doi: 10.1002/ejhf.1330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1330</ArticleId><ArticleId IdType="pubmed">30411833</ArticleId></ArticleIdList></Reference><Reference><Citation>Achenbach S, Fuchs F, Goncalves A, et al. Non-invasive imaging as the cornerstone of cardiovascular precision medicine. Eur Heart J Cardiovasc Imaging. 2022;23:465&#x2013;475. doi: 10.1093/ehjci/jeab287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeab287</ArticleId><ArticleId IdType="pubmed">35048106</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>